Every BriefAsia story tagged Pharmaceuticals, newest first.
South Korean contract manufacturer will issue 2.27 million new shares at discounted price as pharmaceutical industry consolidation accelerates
Pharmaniaga's quarterly earnings surge reflects aggressive deleveraging and a landmark insulin contract that positions the firm for biopharmaceutical expansion across Southeast Asia
Korean biopharma's Q2 profit jumped 86% on stronger biosimilar demand, pushing operating margin past 32% for the first time
Korean biotech firm signs exclusive agreement with global pharma partner to commercialize proprietary enzyme technology for biologic drug delivery
The South Korean biotech giant aims to expand into obesity and diabetes drug production through the all-cash acquisition of PolyPeptide
The Mumbai-based drugmaker recorded positive returns across multiple timeframes, with trading volumes nearing recent averages amid sustained investor interest in Indian pharmaceutical equities.
